MétaCan
Menu
Back to cohort

THYMOGLOBULIN SIGNIFICANTLY REDUCES THE RISK OF ACUTE REJECTION IN RIGHT LOBE LIVING-DONOR LIVER TRANSPLANT (LDLT) RECIPIENTS

2004· article· en· W2072355837 on OpenAlexaff
M. Cattral, Ian D. McGilvray, Lesley Adcock, Leslie Lilly, Nigel Girgrah, Gal Levy, Paul D. Greig, Debra Grant

Bibliographic record

VenueTransplantation · 2004
Typearticle
Languageen
FieldMedicine
TopicCytomegalovirus and herpesvirus research
Canadian institutionsToronto General HospitalUniversity of Toronto
Fundersnot available
KeywordsThymoglobulinMedicineGastroenterologyTacrolimusLiver transplantationInternal medicineSurgeryTransplantation

Abstract

fetched live from OpenAlex

P514 Aims: Thymoglobulin (Thymo) has been reported to reduce the risk of rejection after transplantation, and may attenuate ischemic-reperfusion injury. The role of Thymo after LDLT, however, remains poorly defined Methods: We compared the outcome of patients that received no polyclonal antibody induction therapy (Group 1; n=36) with those that received a course of Thymo (Group 2; n=46). Thymo was initiated within the first 6 hrs after LDLT and continued for 3-7days; daily dosage was adjusted to maintain absolute lymphocyte counts of <0.2. All patients received a tapering dosage of methylprednisolone and tacrolimus (Tac; group 1, 84%; group 2, 90%) or Neoral cyclosporine (Cya; group 1, 16%; group 2, 10%; p=NS). In group 2, initiation of Cya/Tac was routinely delayed to the 3rd -5th post-op day. Ganciclovir was given for 3 mo. to all CMV+ recipients that received Thymo and to all CMV- recipients of CMV+ grafts. All complications were recorded prospectively. Results: Demographic characteristics (age, sex, cause of liver disease) were similar in both groups. Median follow-up was 996 days in group 1 and 429 days in group 2 (P<0.01). The proportion of patients free of rejection during the first 6 months was 62% in group 1 and 91% in group 2 (p <0.001 by Log rank test). Six patients in group 1 had steroid-resistant rejection requiring OKT3 (n=5) or thymo (n=1); all 6 of these patients were receiving tacrolimus. All rejection episodes in group 1 were mild and treated successfully with steroids. Thymo was well-tolerated in all patients. There was no significant difference in the incidence of bacterial, fungal, or CMV infection in the two groups. One patient in group 2 that acquired EBV from the graft developed PTLD, which has been treated successfully. Among Hepatitis C virus infected (HCV)-patients the incidence and severity of recurrent HCV was similar in group 1 and 2. Patient and graft survival at 2 years was 86% and 84% in group 1, and 86% and 86% in group 2, respectively. Causes of death in group 1 were small graft syndrome (n=2), myocardial infarction (1), and sepsis (2); and in group 2 were, recurrent hepatoma (1), lung cancer (1), and sepsis (3). Conclusions: Thymo significantly reduces the risk of acute rejection in LDLT recipients without increasing the risk of infectious complications. Reducing the risk of rejection may be valuable in recipients of marginal size grafts in whom rejection may compromise function, impair regeneration, and promote graft failure.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.002

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.281
Teacher spread0.263 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2004
Admission routes1
Has abstractyes

Explore more

Same venueTransplantationSame topicCytomegalovirus and herpesvirus researchFrench-language works237,207